famotidine has been researched along with Cancer of Duodenum in 3 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzales-Rosales, F | 1 |
| Walsh, D | 1 |
| Burkons, L | 1 |
| Burkons, J | 1 |
| Horvitz, HR | 1 |
| Pisegna, JR | 1 |
| Norton, JA | 1 |
| Slimak, GG | 1 |
| Metz, DC | 1 |
| Maton, PN | 1 |
| Gardner, JD | 1 |
| Jensen, RT | 1 |
| Isobe, Y | 1 |
| Nagai, H | 1 |
| Muramatsu, M | 1 |
| Aihara, H | 1 |
| Otomo, S | 1 |
1 trial available for famotidine and Cancer of Duodenum
| Article | Year |
|---|---|
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Duodenal Neoplasms; Famotidine; Female; F | 1992 |
2 other studies available for famotidine and Cancer of Duodenum
| Article | Year |
|---|---|
Chronic bleeding secondary to an unresectable duodenal adenocarcinoma controlled with sucralfate and famotidine.
Topics: Adenocarcinoma; Aged; Duodenal Neoplasms; Famotidine; Female; Gastrointestinal Agents; Gastrointesti | 1998 |
Antisecretory and antilesional effect of a new histamine H2-receptor antagonist, IT-066, in rats.
Topics: Animals; Cimetidine; Cold Temperature; Cysteamine; Dose-Response Relationship, Drug; Duodenal Neopla | 1990 |